[email protected]22 Feb, 2023Business
The increasing participation of key players is one of the key factors driving the craniomaxillofacial devices market. In 2019, Kelyniam Global (KLYG) received premarket FDA approval for unique modifications to their PEEK cranio-maxillofacial implant product line. Various other factors such as the acceptance of craniomaxillofacial devices market in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and growing demand for bioresorbable devices are also expected to propel the growth of the market.
Flood Williams
Guldbrandsen Vittrup
Abbott Pritchard
Christensen Farah
May Rocha
Md Osman
Espersen Crane
Jiles Capital Investment Group, Llc
New88
Mcguire Pace